Sensei Biotherapeutics Ownership | Who Owns Sensei Biotherapeutics?


OverviewForecastRevenueFinancialsChart

Sensei Biotherapeutics Ownership Summary


Sensei Biotherapeutics is owned by 8.79% institutional investors, 34.39% insiders, and 56.82% retail investors. Ikarian capital is the largest institutional shareholder, holding 2.59% of SNSE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.93% of its assets in Sensei Biotherapeutics shares.

SNSE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSensei Biotherapeutics8.79%34.39%56.82%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ikarian capital650.00K2.59%$403.06K
Vanguard group618.76K2.47%$383.69K
Renaissance223.78K0.89%$138.77K
Boothbay fund management172.84K0.69%$107.17K
Geode capital management163.14K0.65%$101.18K
Bridgeway capital management77.90K0.31%$48.31K
Northern trust25.98K0.10%$16.11K
State street25.77K0.10%$15.98K
Cresset asset management19.67K0.08%$12.20K
Citadel advisors15.37K0.06%$9.53K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital650.00K0.07%$403.06K
Deuterium capital management11.00K0.01%$6.82K
Boothbay fund management172.84K0.00%$107.17K
Bridgeway capital management77.90K0.00%$48.31K
Xtx topco14.05K0.00%$8.71K
Renaissance223.78K0.00%$138.77K
Tower research capital llc (trc)7.09K0.00%$4.39K
Cresset asset management19.67K0.00%$12.20K
Two sigma securities---
Two sigma advisers, lp---

Top Buyers

HolderShares% AssetsChange
Ikarian capital650.00K0.07%650.00K
Boothbay fund management172.84K0.00%172.84K
Vanguard group618.76K-44.91K
Geode capital management163.14K-26.82K
Xtx topco14.05K0.00%14.05K

Top Sellers

HolderShares% AssetsChange
Newtyn management---930.23K
Bank of america corp /de/139.00--90.62K
Bridgeway capital management77.90K0.00%-35.00K
Millennium management---32.59K
Blackrock7.78K--25.80K

New Positions

HolderShares% AssetsChangeValue
Ikarian capital650.00K0.07%650.00K$403.06K
Boothbay fund management172.84K0.00%172.84K$107.17K
Xtx topco14.05K0.00%14.05K$8.71K
National bank of canada /fi/10.00K-10.00K$5.90K

Sold Out

HolderChange
Qube research-4.00
Wells fargo & company/mn-133.00
Ubs group-139.00
Banque cantonale vaudoise-3.90K
Two sigma investments, lp-10.18K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202419-17.39%2,206,8174.71%812.42%5-50.00%5-
Jun 30, 202423-4.17%2,107,576-8.74%812.33%1066.67%5-16.67%
Mar 31, 2024244.35%2,309,379-22.04%86.13%620.00%6-
Dec 31, 2023234.55%2,962,310-4.73%1111.18%566.67%6-
Sep 30, 202322-15.38%3,109,261-1.11%109.82%3-57.14%6-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv485.96K1.93%-
Vanguard Institutional Extnd Mkt Idx Tr99.62K0.40%-
Fidelity Extended Market Index92.47K0.37%-374.00
Bridgeway Ultra-Small Company Market47.90K0.19%-30.00K
Fidelity Total Market Index28.33K0.11%-
Vanguard Balanced Index Inv18.11K0.07%-
Northern Trust Extended Eq Market Idx17.92K0.07%-
NT Ext Equity Mkt Idx Fd - L17.92K0.07%-
Fidelity Series Total Market Index17.48K0.07%-
Fidelity Nasdaq Composite Index16.93K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2023Celebi John President and CEOBuy$425.00
Jun 01, 2023Apeiron Investment Group Ltd.-Sell$1.51M
Feb 23, 2023Apeiron Investment Group Ltd.-Buy$1.76K
Feb 23, 2023Apeiron Investment Group Ltd.-Buy$1.78K
Mar 02, 2022Peyer James Buy$3.85K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q1--
2023 Q4--
2023 Q31-
2023 Q2-1

SNSE Ownership FAQ


Who Owns Sensei Biotherapeutics?

Sensei Biotherapeutics shareholders are primarily institutional investors at 8.79%, followed by 34.39% insiders and 56.82% retail investors. The average institutional ownership in Sensei Biotherapeutics's industry, Biotech Stocks , is 47.04%, which Sensei Biotherapeutics falls below.

Who owns the most shares of Sensei Biotherapeutics?

Sensei Biotherapeutics’s largest shareholders are Ikarian capital (650K shares, 2.59%), Vanguard group (618.76K shares, 2.47%), and Renaissance (223.78K shares, 0.89%). Together, they hold 5.96% of Sensei Biotherapeutics’s total shares outstanding.

Does Blackrock own Sensei Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Sensei Biotherapeutics.

Who is Sensei Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Sensei Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 0.07% of its assets in 650K Sensei Biotherapeutics shares, valued at 403.06K$.

Who is the top mutual fund holder of Sensei Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Sensei Biotherapeutics shares, with 1.93% of its total shares outstanding invested in 485.96K Sensei Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools